查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1655425

全球奈米生物技術市場

Nanobiotechnology
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 212 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年全球奈米生物技術市場規模將達到 1,788 億美元

2024 年全球奈米生物技術市場規模估計為 1,194 億美元，預計到 2030 年將達到 1,788 億美元，2024-2030 年分析期內的複合年成長率為 7.0%。製藥和生物技術最終用途產業是報告中分析的細分市場之一，預計到分析期結束時複合年成長率為 7.6%，達到 1227 億美元。在分析期內，醫療設備最終用途部分的複合年成長率預計為 5.7%。

美國市場預計將達到 332 億美元，中國市場複合年成長率為 6.5%

預計2024年美國奈米生物技術市場規模將達332億美元。中國是世界第二大經濟體，預計到 2030 年市場規模將達到 276 億美元，2024-2030 年分析期間的複合年成長率為 6.5%。其他值得注意的區域市場包括日本和加拿大，預計在分析期間的複合年成長率分別為 6.6% 和 5.3%。在歐洲，德國的複合年成長率預計為 5.6%。

全球奈米薄膜市場 - 主要趨勢與促進因素摘要

什麼是奈米薄膜？

奈米薄膜是一種厚度僅為幾奈米的超薄膜，應用於表面可增強功能和性能。這些薄膜由多種材料製成，包括金屬、陶瓷和聚合物，每種材料都具有高電導性、優異的強度、耐腐蝕性和耐磨性等獨特性能。其應用領域多種多樣，涵蓋電子、醫療保健、能源和汽車等工業領域。例如，在電子領域，奈米薄膜可用於提高智慧型手機和電視等設備的螢幕亮度和色彩質量，從而提高其效率和性能。在醫療保健領域，奈米薄膜有助於開發更有效的藥物傳輸系統和先進的診斷工具。

科技進步如何影響奈米薄膜的發展？

技術進步在奈米薄膜的發展中發揮著至關重要的作用，尤其是在其生產和應用方法方面。原子層沉積 (ALD)、化學氣相沉積 (CVD) 和物理氣相沉積 (PVD) 等技術可以精確控制這些薄膜的厚度和成分，從而能夠根據特定行業需求提供量身定做的解決方案。奈米技術的創新也導致了可以對溫度、光和壓力等環境刺激做出反應的智慧奈米薄膜的產生。這種響應薄膜在感測器和穿戴式技術中的應用越來越廣泛，它提供的自適應特性可增強裝置功能和使用者互動。

哪些市場趨勢將塑造奈米薄膜的未來？

奈米薄膜市場受到影響需求和供應動態的幾個關鍵趨勢的影響。一個主要趨勢是對更智慧、更小型化的電子設備的需求不斷增加。隨著設備變得越來越小，其功能也越來越強大，對於能夠在更小尺寸下發揮作用的先進材料的需求也日益增加。奈米膜透過在薄層中提供高性能來滿足這些需求，使其成為小型電子設備的理想材料。另一個趨勢是人們越來越關注永續性，這引起了人們對有助於提高能源效率的奈米薄膜的興趣，例如用於太陽能電池板和節能窗戶的奈米薄膜。此外，汽車產業向電動車的轉變推動了對輕質、耐用材料的需求，奈米薄膜被用於延長電池壽命和提高車輛性能。

推動奈米薄膜市場成長的因素是什麼？

奈米薄膜市場的成長受到多種因素的推動，例如奈米技術和材料科學的不斷進步，以及奈米薄膜在各個行業中品質和適用性的提高。電子產業蓬勃發展，對更小、更快、更有效率的設備的需求不斷增加，嚴重依賴奈米薄膜技術來滿足這些需求。此外，隨著世界轉向更多可再生能源來源，奈米薄膜在能源領域，特別是太陽能應用領域的使用日益增多，正在支持市場的成長。尤其是隨著越來越多的消費者要求產品具有良好的性能、耐用性和節能性，情況就更是如此。此外，促進環境永續性的監管趨勢正在鼓勵採用有助於減少環境影響的奈米薄膜等創新材料。總的來說，這些因素推動了奈米薄膜市場的蓬勃發展，反映了奈米薄膜在現代技術應用中的重要角色。

部分

最終用途（製藥和生物技術產業、醫療設備）

受訪企業範例（共79家）

  • Ablynx NV
  • Arrowhead Pharmaceuticals Inc.
  • CaPtivate Pharmaceuticals LLC
  • Celgene Corporation
  • ELITechGroup
  • Flamel Technologies SA
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • Merck & Co. Inc.
  • NanoBio（R）Corporation
  • Nanophase Technologies Corporation
  • pSivida Corp.
  • Sigma-Aldrich Corp.
  • Starpharma Holdings Ltd.
  • Vectura Group plc

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 其他地區

第4章 競賽

簡介目錄
Product Code: MCP-1476

Global Nanobiotechnology Market to Reach US$178.8 Billion by 2030

The global market for Nanobiotechnology estimated at US$119.4 Billion in the year 2024, is expected to reach US$178.8 Billion by 2030, growing at a CAGR of 7.0% over the analysis period 2024-2030. Pharmaceuticals & Biotechnology Industry End-Use, one of the segments analyzed in the report, is expected to record a 7.6% CAGR and reach US$122.7 Billion by the end of the analysis period. Growth in the Medical Devices End-Use segment is estimated at 5.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$33.2 Billion While China is Forecast to Grow at 6.5% CAGR

The Nanobiotechnology market in the U.S. is estimated at US$33.2 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$27.6 Billion by the year 2030 trailing a CAGR of 6.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.6% and 5.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.6% CAGR.

Global Nanofilms Market - Key Trends & Drivers Summarized

What Are Nanofilms and How Are They Revolutionizing Industries?

Nanofilms are ultra-thin layers of material, often just a few nanometers thick, applied to surfaces to enhance their functionality or performance. These films can be composed of different materials, including metals, ceramics, and polymers, each offering unique properties such as high conductivity, exceptional strength, and resistance to corrosion and wear. Their applications are diverse and span across industries including electronics, healthcare, energy, and automotive. In electronics, for instance, nanofilms are used to improve the efficiency and performance of devices like smartphones and TVs by enhancing screen brightness and color quality. In the healthcare sector, nanofilms contribute to the development of more efficient drug delivery systems and advanced diagnostic tools.

How Are Technological Advancements Influencing Nanofilm Developments?

Technological advancements play a pivotal role in the development of nanofilms, particularly in the methods used for their fabrication and application. Techniques such as atomic layer deposition (ALD), chemical vapor deposition (CVD), and physical vapor deposition (PVD) allow for precise control over the thickness and composition of these films, enabling tailor-made solutions for specific industry needs. Innovations in nanotechnology have also led to the creation of smart nanofilms, which can respond to environmental stimuli such as temperature, light, and pressure. These responsive films are increasingly used in sensors and wearable technology, offering adaptive properties that enhance device functionality and user interaction.

What Market Trends Are Shaping the Future of Nanofilms?

The nanofilm market is being shaped by several significant trends that are influencing both demand and supply dynamics. One of the major trends is the increasing demand for high-performance, miniaturized electronics. As devices become smaller and their functionality increases, the need for advanced materials that can perform at these reduced dimensions grows. Nanofilms meet these requirements by enabling high performance in thin layers, making them ideal for compact electronic devices. Another trend is the growing focus on sustainability, driving interest in nanofilms that contribute to energy efficiency, such as those used in solar panels and energy-efficient windows. Additionally, the automotive industry's shift towards electric vehicles has increased the need for lightweight, durable materials, where nanofilms are used to enhance battery life and vehicle performance.

What Drives the Growth of the Nanofilm Market?

The growth in the nanofilm market is driven by several factors, including the continued advancement of nanotechnology and material science, which enhances the quality and applicability of nanofilms across various industries. The booming electronics sector, with its constant demand for smaller, faster, and more efficient devices, heavily relies on nanofilm technology to meet these requirements. Additionally, the increasing utilization of nanofilms in the energy sector, particularly in solar energy applications, supports market growth as the world moves towards more renewable energy sources. Consumer behavior also influences this growth, especially as more consumers demand high-performance, durable, and energy-efficient products. Moreover, regulatory trends promoting environmental sustainability encourage the adoption of innovative materials like nanofilms to help reduce environmental impact. These factors collectively drive the dynamic expansion of the nanofilm market, reflecting its integral role in modern technological applications.

SCOPE OF STUDY:

The report analyzes the Nanobiotechnology market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

End-Use (Pharmaceuticals & Biotechnology Industry, Medical Devices)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 79 Featured) -

  • Ablynx NV
  • Arrowhead Pharmaceuticals Inc.
  • CaPtivate Pharmaceuticals LLC
  • Celgene Corporation
  • ELITechGroup
  • Flamel Technologies SA
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • Merck & Co. Inc.
  • NanoBio(R) Corporation
  • Nanophase Technologies Corporation
  • pSivida Corp.
  • Sigma-Aldrich Corp.
  • Starpharma Holdings Ltd.
  • Vectura Group plc

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Nanobiotechnology - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Advances in Nanotechnology Propel Growth in Nanobiotechnology Market
    • Increasing Demand for Targeted Drug Delivery Expands Addressable Market Opportunity
    • Growth in Diagnostic and Imaging Applications Generates Demand for Nanobiotechnology Solutions
    • Technological Innovations in Nanomedicine Strengthen Business Case for Nanobiotechnology
    • Integration of Nanomaterials in Regenerative Medicine Spurs Growth in Healthcare Sector
    • Demand for Precision Medicine Expands the Market for Nanobiotechnology
    • Advances in Nano-Scale Imaging and Sensing Technologies Generate Demand for Innovative Solutions
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Nanobiotechnology Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Nanobiotechnology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Nanobiotechnology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Nanobiotechnology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Pharmaceuticals & Biotechnology Industry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Pharmaceuticals & Biotechnology Industry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Pharmaceuticals & Biotechnology Industry by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Medical Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Medical Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Medical Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Nanobiotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 11: USA Recent Past, Current & Future Analysis for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 12: USA Historic Review for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: USA 15-Year Perspective for Nanobiotechnology by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals & Biotechnology Industry and Medical Devices for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 14: Canada Recent Past, Current & Future Analysis for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 15: Canada Historic Review for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: Canada 15-Year Perspective for Nanobiotechnology by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals & Biotechnology Industry and Medical Devices for the Years 2015, 2025 & 2030
  • JAPAN
    • Nanobiotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 17: Japan Recent Past, Current & Future Analysis for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 18: Japan Historic Review for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: Japan 15-Year Perspective for Nanobiotechnology by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals & Biotechnology Industry and Medical Devices for the Years 2015, 2025 & 2030
  • CHINA
    • Nanobiotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 20: China Recent Past, Current & Future Analysis for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 21: China Historic Review for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: China 15-Year Perspective for Nanobiotechnology by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals & Biotechnology Industry and Medical Devices for the Years 2015, 2025 & 2030
  • EUROPE
    • Nanobiotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 23: Europe Recent Past, Current & Future Analysis for Nanobiotechnology by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: Europe Historic Review for Nanobiotechnology by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: Europe 15-Year Perspective for Nanobiotechnology by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 26: Europe Recent Past, Current & Future Analysis for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: Europe 15-Year Perspective for Nanobiotechnology by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals & Biotechnology Industry and Medical Devices for the Years 2015, 2025 & 2030
  • FRANCE
    • Nanobiotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 29: France Recent Past, Current & Future Analysis for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: France Historic Review for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: France 15-Year Perspective for Nanobiotechnology by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals & Biotechnology Industry and Medical Devices for the Years 2015, 2025 & 2030
  • GERMANY
    • Nanobiotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 32: Germany Recent Past, Current & Future Analysis for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Germany Historic Review for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: Germany 15-Year Perspective for Nanobiotechnology by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals & Biotechnology Industry and Medical Devices for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 35: Italy Recent Past, Current & Future Analysis for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Italy Historic Review for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: Italy 15-Year Perspective for Nanobiotechnology by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals & Biotechnology Industry and Medical Devices for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Nanobiotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 38: UK Recent Past, Current & Future Analysis for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: UK Historic Review for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: UK 15-Year Perspective for Nanobiotechnology by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals & Biotechnology Industry and Medical Devices for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 41: Rest of Europe Recent Past, Current & Future Analysis for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Rest of Europe Historic Review for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Rest of Europe 15-Year Perspective for Nanobiotechnology by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals & Biotechnology Industry and Medical Devices for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Nanobiotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 44: Asia-Pacific Recent Past, Current & Future Analysis for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Asia-Pacific Historic Review for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Asia-Pacific 15-Year Perspective for Nanobiotechnology by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals & Biotechnology Industry and Medical Devices for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 47: Rest of World Recent Past, Current & Future Analysis for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Rest of World Historic Review for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Rest of World 15-Year Perspective for Nanobiotechnology by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals & Biotechnology Industry and Medical Devices for the Years 2015, 2025 & 2030

IV. COMPETITION